Related Experiment Video
Updated: Apr 21, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Pathological role for exocytotic glutamate release from astrocytes in hepatic encephalopathy
Vedrana Montana1, Alexei Verkhratsky2, Vladimir Parpura1
1Department of Neurobiology, Center for Glial Biology in Medicine, Atomic Force Microscopy & Nanotechnology Laboratories, Civitan International Research Center, Evelyn F. McKnight Brain Institute, University of Alabama, Birmingham, AL 35294, USA ; Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
Abstract:
Liver failure can lead to generalized hyperammonemia, which is thought to be the underlying cause of hepatic encephalopathy. This neuropsychiatric syndrome is accompanied by functional changes of astrocytes. These glial cells enter ammonia-induced self-amplifying cycle characterized by brain oedema, oxidative and osmotic stress that causes modification of proteins and RNA. Consequently, protein expression and function are affected, including that of glutamine synthetase and plasmalemmal glutamate transporters, leading to glutamate excitotoxicity; Ca(2+)-dependent exocytotic glutamate release from astrocytes contributes to this extracellular glutamate overload.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis ll: Pathophysiology
Antiepileptic Drugs: Glutamate Antagonists
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Glial Cells

